Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Total Liabilities (2016 - 2026)

Bioceres Crop Solutions' Total Liabilities history spans 11 years, with the latest figure at $433.9 million for Q1 2026.

  • On a quarterly basis, Total Liabilities changed N/A to $433.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $433.9 million, a N/A change, with the full-year FY2025 number at $468.4 million, down 6.54% from a year prior.
  • Total Liabilities hit $433.9 million in Q1 2026 for Bioceres Crop Solutions, down from $468.4 million in the prior quarter.
  • Over the last five years, Total Liabilities for BIOX hit a ceiling of $501.2 million in Q2 2024 and a floor of $359.9 million in Q2 2022.
  • Historically, Total Liabilities has averaged $450.2 million across 5 years, with a median of $468.4 million in 2025.
  • Biggest five-year swings in Total Liabilities: soared 35.46% in 2023 and later decreased 6.54% in 2025.
  • Tracing BIOX's Total Liabilities over 5 years: stood at $359.9 million in 2022, then soared by 35.46% to $487.6 million in 2023, then grew by 2.79% to $501.2 million in 2024, then dropped by 6.54% to $468.4 million in 2025, then dropped by 7.37% to $433.9 million in 2026.
  • Business Quant data shows Total Liabilities for BIOX at $433.9 million in Q1 2026, $468.4 million in Q2 2025, and $501.2 million in Q2 2024.